BioCenter Events
Past Events
Partner Events
Subscribe to our
Events & News Alert
Trends in Financing Investor Panel
& Holiday Celebration
An Industry Panel and Networking Reception
Thursday December 3, 2009


Agenda
3:00 PM - 3:30 PM   Registration and Networking
3:30 PM - 5:00 PM   Industry Panel
5:00 PM - 6:30 PM   Holiday Celebration Networking Reception

Steady capital is a must for all companies. The first step in funding is knowing where to look. Join experts from the investment world at our annual “Trends in Financing Investor Panel & Holiday Celebration” to understand the types of financing that are occurring in your industry today - including topics such as who is getting funding while the world faces complex financial challenges - and what is new and to expect for 2010.

Our Panel discussions are candid, interactive and informal. We want you to walk away with the real story behind how things work so you can make it happen yourself. This Panel will be followed by a Holiday Celebration Networking Reception.

Speakers
Janis Naeve, PhD, Director, Amgen Ventures
Doug Fisher, Principal, InterWest Partners LLC
Sarah Bodary, PhD, Venture Partner, SV Life Sciences
Jim Long, Partner, Gabriel Venture Partners
• Lead Facilitator: Stephen Venuto, Partner, Orrick, Herrington & Sutcliffe LLP

Speakers Bios

Janis Naeve, PhD, Director, Amgen Ventures
Dr. Janis Naeve joined Amgen in 2005 and is currently Director for Amgen Ventures, the Company’s corporate venture capital fund. She manages deal flow evaluation and on-going oversight of investments in multiple portfolio companies. Before joining Amgen, Dr. Naeve was Director of Corporate Development for X-Ceptor Therapeutics where she supported strategic planning including repositioning the company’s platform to a cardiovascular drug company. Her broad-based experience encompasses revenue generation in a profitable biotech, transitioning of a platform research company into preclinical/clinical development, and fundraising through venture capital or M&A.; Naeve did her postdoctoral research work at Caltech after receiving her Ph.D. in Experimental Pathology from the University of Southern California. Naeve completed her undergraduate work in Medical Microbiology at California Polytechnic University.


Doug Fisher, Principal, InterWest Partners LLC
Dr. Doug Fisher joined InterWest's life sciences team in 2009, focusing on biopharmaceutical and diagnostics investments. Prior to joining InterWest, Dr. Fisher was a vice president at New Leaf Venture Partners where he spent three years focusing on biopharmaceutical, medical device, and diagnostics investments. He was involved with several investments, including: Pearl Therapeutics, Access Closure, and GluMetrics. Prior to joining New Leaf, Dr. Fisher was a project leader with The Boston Consulting Group where he was a member of the Health Care Practice Area and consulted for leading pharmaceutical and biotech companies. Previously, he worked for Centocor (a J&J; operating company) in the Global Biologic Strategic Marketing Group where he developed product strategies in three new disease areas for Remicade.
Dr. Fisher received an A.B. in economics with honors and distinction and a B.S. in biology with distinction from Stanford where he graduated Phi Beta Kappa. He has an M.D. from the University of Pennsylvania School of Medicine and an M.B.A. from Wharton where he graduated with honors as a Siebel Scholar and Palmer Scholar.


Sarah Bodary, PhD, Venture Partner, SV Life Sciences
Dr Sarah Bodary joined SVLS in October 2008 and is focused on biotech investments.
Sarah has 20 years experience in research, drug development and licensing in the biotech industry. As a biologist at Genentech she led teams that developed peptide and small molecule antagonists of cell adhesion from discovery through clinical trials. She was also a member of the development and launch teams for the Raptiva ®. antibody. Most recently Sarah was responsible for licensing at Schering-Plough Biopharma, the biologics subsidiary of Schering-Plough Corporation.
Sarah received a B.Sc. in Molecular Biology from the University of Edinburgh, Scotland, a Ph.D. in Biology from the University of Lausanne, Switzerland and completed a Postdoctorate in Molecular Neurobiology at the Howard Hughes Medical Institute of the University of California at San Francisco.


Jim Long, Partner, Gabriel Venture Partners
Jim Long joined Gabriel as a Venture Partner in early 2007, and drives new investments as well as advises existing Gabriel portfolio companies. Jim has over 20 years experience as a founder, CEO, and business leader building successful businesses in the technology industry, as well as developing new technologies and patents for the Internet and PC environments. He has been a founder, CEO, and executive at leading technology companies, and has served as an advisor to many startups and venture capital firms.
Venture Capital Experience
After doing software and product marketing at Hewlett Packard, Jim was one of the first MBA’s hired in the venture capital industry in 1982, when he joined Fred Adler Ventures. In his four years at the firm Jim was acting CEO at several turnarounds and worked with veteran VCs Jim Swartz and Arthur Patterson prior to them founding Accel Partners. Over the years, Jim has also done projects with venture firms Accel Partners, Crosspoint Venture Partners, IT-Farm (Japan), and Sequoia Capital. Jim’s venture experience also includes interim CEO jobs and “turn-arounds” at companies such as Linkware (acquired by Ungermann-Bass). As an angel advisor/investor, Jim has been involved with several leading startups, including TiMetra (acquired by Alcatel), Manageware (acquired by Computer Associates), Ruckus Wireless (WiFi video leader), Coghead (SaaS for the long tail); Ready Systems (acquired by Mentor), and Jibe Networks (acquired by Citrix).
Investment Focus
Jim has a wide depth and breadth of experience in the technology industry, and focuses on investments in emerging cleantech, software, and consumer Internet companies, identifying disruptive business models with a capital efficient focus. He has helped direct investments at Gabriel in next-generation biofuels production, social software for the enterprise market, and innovative gardening technology.
Entrepreneurial Experience
Before joining Gabriel, Jim was a serial entrepreneur for most of the last 20 years. Most recently, Jim was CEO of RioPort, a leading music application service provider RioPort, powered MTV.com, Best-Buy.com, Yahoo, HP, Nike.com, and Microsoft, was the first Internet company to license digital songs for resale from all five major record labels and enabled the first music cell-phones via a partnership with Nokia. Considered the “father of streaming video," Jim was also CEO and founder of Starlight Networks, which pioneered video streaming and video multicasting with award-winning Intranet video infrastructure software. Starlight Networks was the leader in the corporate video streaming market when it was acquired by PictureTel in July 1998. Previously, Jim was one of the four founders of Tolerant Software, which became Veritas (VRTS) a leader in the storage management software market. Veritas was acquired by Symantec for over $12 Billion long after Jim left to invent video streaming.
Operating Experience
Jim began his career in software development and product marketing at Hewlett Packard, where he invented the first presentation graphics application and worked in Europe. During his career building and running startups as a CEO, Jim honed his management, startup, and business operational experience, wearing all the hats necessary to build successful businesses. He has built and worked with companies from the ground-up and led them through acquisition or IPO, helped turn around ailing companies, and invented new business strategies, such as SaaS models and new software development infrastructures, for several different companies. As an angel investor and advisor, Jim has worked with dozens of startups to help them execute successful business and technology strategies. Jim also spent a summer at the Boston Consulting Group during business school.
Board Memberships and Affiliations
Jim currently serves on the boards of Aurora BioFuels, Connectbeam, PlantSense, and YLX. Jim has previously served on boards of over a dozen other startup companies, as well as community organizations like the Las Lomitas Education Foundation.
Philanthropy
Jim currently contributes money and time to schools, children’s organizations, and local community groups.
Education
MBA – Harvard University (with distinction)
BS – Electrical Engineering and Computer Science, UC Berkeley


Lead Facilitator: Stephen Venuto, Partner, Orrick, Herrington & Sutcliffe LLP
Stephen Venuto, a corporate partner, focuses on the representation of high growth technology and media companies, their founders and investors. He is also a member of Orrick's Leadership Team as the firmwide head of on-campus attorney recruiting, and is a managing member of Orrick's venture fund.
His practice includes the formation, financing and general corporate counseling of emerging growth private and public companies; representation of venture capital firms and investment banks in private and public offerings; and other complex transactions. Most of Mr. Venuto's clients are in fast growth fields related to biotechnology, clean technology, information technology, media and/or entertainment. Mr. Venuto has completed hundreds of venture capital financings and numerous public offerings, mergers, acquisitions and licensing transactions.
Some of Mr. Venuto's clients have included:
• AcroMetrix (biotech - funded by Telegraph Hill Partners)
• Attributor (Internet)
• BenefitPoint (medical insurance brokerage service - funded by HarbourVest Partners, HLM Venture Partners, Institutional Venture Partners, Sequoia Capital, and Trident Capital)
• ENDFORCE (Internet - funded by Kleiner Perkins Caufield & Byers, INVESCO Private Capital, WK Technology Fund)
• Facebook (Internet - funded by Accel Partners, Greylock, Meritech and Peter Thiel and others)
• Geni (Internet - founded by David Sacks, funded by Charles River Ventures and Founders Fund)
• Greenplum (database - funded by Dawntreader, EDF, Hudson & Mission)
• Halycon Molecular (biotechnology)
• Handmark (gaming - funded by Apax Partners and David Hanna)
• Iridigm Display (semiconductor & display - sold to Qualcomm)
• Laserscope (medical device - publicly traded company, sold)
• Modelinia (new media - founded by Desiree Gruber, funded by Polaris Ventures)
• Ooma (consumer electronics - funded by Draper Fisher Jurvetson, Founders Fund, and Worldview Technology Partners)
• Powerset (Internet search - sold to Microsoft, funded by Foundation Capital and Founders Fund)
• PureVideo Networks (Internet - funded by Softbank Capital)
• Renkoo (Internet)
• VideoEgg (Internet advertising - funded by August Capital and others)
• W5 Networks (electronic shelf labels and RFID - funded by Thomas Weisel Venture Partners and U.S. Venture Partners)
• Xobni (e-mail - funded by First Round Capital, Khosla Ventures and others)
• Yammer (Internet - founded by David Sacks)
Mr. Venuto also has represented many venture capital and investment banking clients including Credit Suisse First Boston, Eastman Kodak’s venture fund, Founders Fund, Goldman, Sachs & Co., Matrix Partners, Thomas Weisel Venture Partners, Trinity Ventures and U.S. Venture Partners. He has worked on numerous public offerings involving such companies as Inktomi, MIPS, Preview Systems, Silicon Graphics and others.
Mr. Venuto has programming experience. He has created and runs his own Web site focused on wine (using PHP and PERL), The Oenophile Network, was an HTML programmer and editor of one of the earliest legal oriented Web sites on the Internet and was the systems operator of several bulletin board systems in the mid '80s.
Before joining the firm, Mr. Venuto was an attorney at Venture Law Group.


Venue
Orrick, Herrington & Sutcliffe LLP
1000 Marsh Road
Building 1100
Menlo Park, CA 94025-1015
Click here for Venue Directions»


© San Jose BioCenter, All Rights Reserved. | [email protected]